Mirae Asset Global Etfs Holdings Ltd. Exact Sciences Corp Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Exact Sciences Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 21,186 shares of EXAS stock, worth $877,735. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,186
Previous 18,955
11.77%
Holding current value
$877,735
Previous $1.07 Million
13.9%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EXAS
# of Institutions
636Shares Held
159MCall Options Held
1.64MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA17.9MShares$742 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA17.8MShares$739 Million0.13% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$518 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$500 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$274 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.33B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...